NOVOS Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.62M
- Investors
-
21
NOVOS General Information
Description
Provider of healthcare drink supplement enriched with anti-aging and longevity qualities intended to improve mental health and wellness. The company's products include nicotinamide riboside, magnesium, fisetin, and pterostilbene as well as antioxidants and other functional ingredients that improve DNA repair and reduce DNA damage, allowing consumers to expand their lifespan and improve their health.
Contact Information
Website
www.novoslabs.comCorporate Office
- 100 Park Avenue
- 16th Floor
- New York, NY 10017
- United States
Corporate Office
- 100 Park Avenue
- 16th Floor
- New York, NY 10017
- United States
NOVOS Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Oct-2021 | $3.62M | Completed | Generating Revenue |
NOVOS Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 |
NOVOS Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NOVOS Patents
NOVOS Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4518832-A1 | Chondroitin- and collagen peptide-based methods for slowing down aging and extending lifespan | Pending | 06-May-2022 | ||
| US-20230085573-A1 | Compositions and methods for treating aging-related disorders | Pending | 01-Feb-2020 | ||
| EP-4096439-A1 | Compositions and methods for treating aging-related disorders | Pending | 01-Feb-2020 | ||
| EP-4096439-A4 | Compositions and methods for treating aging-related disorders | Pending | 01-Feb-2020 | A61K31/09 |
NOVOS Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NOVOS Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Arkitekt Ventures | Venture Capital | Minority | ||
| Asia Venture Group | Venture Capital | Minority | ||
| Awesome People Ventures | Venture Capital | Minority |
NOVOS FAQs
-
When was NOVOS founded?
NOVOS was founded in 2018.
-
Where is NOVOS headquartered?
NOVOS is headquartered in New York, NY.
-
What is the size of NOVOS?
NOVOS has 32 total employees.
-
What industry is NOVOS in?
NOVOS’s primary industry is Pharmaceuticals.
-
Is NOVOS a private or public company?
NOVOS is a Private company.
-
What is the current valuation of NOVOS?
The current valuation of NOVOS is .
-
What is NOVOS’s current revenue?
The current revenue for NOVOS is .
-
How much funding has NOVOS raised over time?
NOVOS has raised $3.62M.
-
Who are NOVOS’s investors?
, , Arkitekt Ventures, Asia Venture Group, and Awesome People Ventures are 5 of 21 investors who have invested in NOVOS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
